ResearchMoz

Leprosy Global Clinical Trials Review, H2, 2012

GlobalData
Published Date » 2012-08-15
No. Of Pages » 59
Leprosy Global Clinical Trials Review, H2, 2012

GlobalData's clinical trial report, Leprosy Global Clinical Trials Review, H2, 2012" provides data on the Leprosy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Leprosy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Leprosy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations 
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Keywords

Leprosy Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Leprosy, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Leprosy 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by BRIC Nations 14
Clinical Trials by G7 Nations 15
Clinical Trials in G7 Nations by Trial Status 16
Clinical Trials by E7 Nations 17
Clinical Trials in E7 Nations by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Subjects Recruited Over a Period of Time 22
Prominent Sponsors 23
Prominent Drug Comparison 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Universities / Institutes / Hospitals 26
London School of Hygiene & Tropical Medicine 26
Clinical Trial Overview of London School of Hygiene & Tropical Medicine 26
University of Colorado 27
Clinical Trial Overview of University of Colorado 27
Leonard Wood Memorial 28
Clinical Trial Overview of Leonard Wood Memorial 28
University of Brasilia 29
Clinical Trial Overview of University of Brasilia 29
Royal Tropical Institute 30
Clinical Trial Overview of Royal Tropical Institute 30
The University of Para 31
Clinical Trial Overview of The University of Para 31
Erasmus MC 32
Clinical Trial Overview of Erasmus MC 32
University of Sao Paulo 33
Clinical Trial Overview of University of Sao Paulo 33
Texas Tech University Health Sciences Center 34
Clinical Trial Overview of Texas Tech University Health Sciences Center 34
Kaiser Permanente 35
Clinical Trial Overview of Kaiser Permanente 35
Five Key Clinical Profiles 36

Appendix 56
Abbreviations 56
Definitions 56
Research Methodology 57
Secondary Research 57
About GlobalData 58
Contact Us 58
Disclaimer 58
Source 59

List of Tables

 
Leprosy Therapeutics Market, Global, Clinical Trials by Zone, 2012* 6
Leprosy Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 7
Leprosy Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 8
Leprosy Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012* 9
Leprosy Therapeutics Clinical Trials, Europe, Top Countries, 2012* 10
Leprosy Therapeutics Clinical Trials, North America, Top Countries, 2012* 11
Leprosy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 12
Leprosy Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 13
Leprosy Therapeutics Clinical Trials, BRIC Countries, 2012* 14
Leprosy Therapeutics Clinical Trials, G7 Countries, 2012* 15
Leprosy Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 16
Leprosy Therapeutics Clinical Trials, E7 Countries, 2012* 17
Leprosy Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 18
Leprosy Therapeutics Market, Global, Clinical Trials by Phase, 2012* 19
Leprosy Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 20
Leprosy Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 21
Leprosy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 22
Leprosy Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 24
Leprosy Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 25
Leprosy Therapeutics Clinical Trials Market, Global, Clinical Trials by London School of Hygiene & Tropical Medicine, 2012* 26
Leprosy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2012* 27
Leprosy Therapeutics Clinical Trials Market, Global, Clinical Trials by Leonard Wood Memorial, 2012* 28
Leprosy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Brasilia, 2012* 29
Leprosy Therapeutics Clinical Trials Market, Global, Clinical Trials by Royal Tropical Institute, 2012* 30
Leprosy Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Para, 2012* 31
Leprosy Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2012* 32
Leprosy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2012* 33
Leprosy Therapeutics Clinical Trials Market, Global, Clinical Trials by Texas Tech University Health Sciences Center, 2012* 34
Leprosy Therapeutics Clinical Trials Market, Global, Clinical Trials by Kaiser Permanente, 2012* 35

List of Figures

List of Figures

Leprosy Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 6
Leprosy Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 7
Leprosy Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 8
Leprosy Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012* 9
Leprosy Therapeutics Clinical Trials, Europe, Top Countries (%), 2012* 10
Leprosy Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012* 13
Leprosy Therapeutics Clinical Trials, BRIC Countries (%), 2012* 14
Leprosy Therapeutics Clinical Trials, G7 Countries (%), 2012* 15
Leprosy Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 16
Leprosy Therapeutics Clinical Trials, E7 Countries (%), 2012* 17
Leprosy Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 18
Leprosy Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 19
Leprosy Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 20
Leprosy Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 21
Leprosy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 22
Leprosy Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 23
Leprosy Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 25
GlobalData Methodology 57

Upcoming Reports:

Anti-Aging Nutraceutical Ingredients Market - Global Industry Analysis, Size, Share, Forecast, 2011 - 2018
By - Transparency Market Research
Nutraceuticals have medicinal properties to treat or prevent diseases and they are food or parts of foods in the form of nutrients. Nutraceuticals foods have high antioxidant properties and are beneficial in fighting the causes of anti-aging. The free radicals produced by the body when cells in our body use oxygen, may cause oxidative damage to the body. Thus, these nutraceuticals help in preventing the side effects of those free radicals. Moreover, the human nature to remain young always has made popular the anti-aging medicines in the market. The rising disposable...
Theranostics Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
Theranostics is the fusion of drug therapy and diagnostics to optimize effectiveness, safety, and streamline drug development. Combination of medical drugs with diagnostic tests is also known as integrated medicine, pharmacodiagnostics, companion diagnostics, and Dx/Rx partnering. Theranostics market is an emerging field which is generating strong interest from healthcare industry and regulatory bodies. It is an emerging clinical diagnostics field that focuses on developing specific analysis to predict the use of most significant drug for patient. This technique uses molecular...
Cardiac Rhythm Management Devices Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts, 2012 - 2018
By - Transparency Market Research
Cardiac Rhythm Management (CRM) devices are used to ensure the proper functioning of the heart. Cardiac Rhythm Management includes devices such as pacemakers and Implantable Cardioverter Defibrillators (ICDs), external defibrillators and cardiac resynchronization therapy devices.   Globally, the incidence of cardiovascular diseases (CVDs) is on the rise. In developed nations cardiovascular disease is the main cause of mortality leading to large number of deaths. There is a consistent demand for cardiac rhythm management devices and this demand will drive the market...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

                    

Related News

One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012  
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012  
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012  
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
Battling against flu, vaccination necessary for health workers
Sep 14, 2012  
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012  
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...